Founded in 2005, Custopharm has steadily grown to develop more than 30 products and serve more than 100 organizations across the pharmaceutical industry. In 2015 we partnered with Water Street Healthcare Partners, a strategic investor with extensive pharmaceutical expertise, to accelerate Custopharm's growth. Since then, we have been working towards becoming a U.S. leader in generic injectable drugs while striving to make therapies more accessible through our development portfolio of high barrier products. The Company is presently in an early commercial stage, with aggressive growth anticipated. Leucadia Pharmaceuticals was established in 2015 as the commercial arm of Custopharm, Inc., and is associated with Water Street Healthcare Partners.